These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26149783)

  • 1. Transdermal iron replenishment therapy.
    Modepalli N; Shivakumar HN; Kanni KL; Murthy SN
    Ther Deliv; 2015; 6(6):661-8. PubMed ID: 26149783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly Dissolving Microneedle Patches for Transdermal Iron Replenishment Therapy.
    Maurya A; Nanjappa SH; Honnavar S; Salwa M; Murthy SN
    J Pharm Sci; 2018 Jun; 107(6):1642-1647. PubMed ID: 29462631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irontophoresis: transdermal delivery of iron by iontophoresis.
    Murthy SN; Vaka SR
    J Pharm Sci; 2009 Aug; 98(8):2670-6. PubMed ID: 19117049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microporation and 'iron'tophoresis for treating iron deficiency anemia.
    Modepalli N; Jo S; Repka MA; Murthy SN
    Pharm Res; 2013 Mar; 30(3):889-98. PubMed ID: 23187864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive transdermal delivery of iron-dextran.
    Juluri A; Modepalli N; Jo S; Repka MA; Shivakumar HN; Murthy SN
    J Pharm Sci; 2013 Mar; 102(3):987-93. PubMed ID: 23280725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant voltage 'Iron'tophoresis.
    Vaka SR; Shivakumar HN; Murthy SN
    Pharm Dev Technol; 2011 Oct; 16(5):483-8. PubMed ID: 20545483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal Delivery of Iron Using Soluble Microneedles: Dermal Kinetics and Safety.
    Modepalli N; Shivakumar HN; McCrudden MT; Donnelly RF; Banga A; Murthy SN
    J Pharm Sci; 2016 Mar; 105(3):1196-200. PubMed ID: 26928401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral iron dextran therapy: a review.
    Burns DL; Mascioli EA; Bistrian BR
    Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal drug delivery.
    Guy RH
    Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.
    Gupta A; Amin NB; Besarab A; Vogel SE; Divine GW; Yee J; Anandan JV
    Kidney Int; 1999 May; 55(5):1891-8. PubMed ID: 10231452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of iron supplementation on iron deficiency anemia of childbearing age women in Shanghai].
    Wang Z; Sun J; Wang L; Zong M; Chen Y; Lin Y; Xu D; Jiang J; Pan Y; Piao J; Huang Z; Yang X
    Wei Sheng Yan Jiu; 2012 Jan; 41(1):51-5. PubMed ID: 22443058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial.
    Tariq N; Ayub R; Khan WU; Ijaz S; Alam AY
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):193-7. PubMed ID: 25772960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous iron-dextran versus peroral iron and blood transfusion for anemia].
    Lewinski U; van der Lijn E; Djaldetti M
    Harefuah; 1973 Aug; 85(4):167-9. PubMed ID: 4756186
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of intravenous iron supplementation in chronic kidney disease: an update.
    Macdougall IC; Geisser P
    Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerability of iron preparation Actiferol Fe® in children treated for iron deficiency anemia].
    Jackowska T; Sapała-Smoczyńska A; Kamińska E
    Dev Period Med; 2015; 19(2):217-24. PubMed ID: 26384126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parenteral iron replacement].
    Cynke E
    Praxis (Bern 1994); 1997 May; 86(20):835-6. PubMed ID: 9312810
    [No Abstract]   [Full Text] [Related]  

  • 17. Delivery systems for improving iron uptake in anemia.
    Trivedi R; Barve K
    Int J Pharm; 2021 May; 601():120590. PubMed ID: 33845149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of parenteral iron dextran therapy.
    Burns DL; Pomposelli JJ
    Kidney Int Suppl; 1999 Mar; 69():S119-24. PubMed ID: 10084295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease].
    Visciano B; Nazzaro P; Tarantino G; Taddei A; Del Rio A; Mozzillo GR; Riccio E; Capuano I; Pisani A
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.